May 10, 2021
May 10, 2021 —
Using a mouse model, researchers discover pivotal role of cholesterol in chronic pain often caused by chemotherapy, and propose novel therapy.
May 10, 2021
May 10, 2021 —
The San Diego Supercomputer Center and CERN team up and leverage an alliance with Strategic Blue, a UK-based Fintech company that helps organizations optimize procurement of cloud services.
May 6, 2021
May 6, 2021 —
Bukata is only the fourth woman in the U.S. to lead a health system’s orthopedic surgery department.
May 6, 2021
May 6, 2021 —
UC San Diego researchers report that one kind of perceptual learning can occur in memory-impaired persons who do not actually remember what they learned.
May 4, 2021
May 4, 2021 —
Researchers at UC San Diego have used gene therapy to prevent learning and memory loss in a mouse model of Alzheimer’s disease, a key step toward eventually testing the approach in humans with the neurodegenerative disease.
April 29, 2021
April 29, 2021 —
Augmented reality headsets give UC San Diego Health spine surgeons “x-ray vision” during procedures for accurate and personalized implant placement, while keeping their eyes on their patients.
April 28, 2021
April 28, 2021 —
Individuals who self-identify as Republicans became more skeptical of a potential COVID-19 vaccine and other inoculations, such as the flu shot, over the course of the pandemic, reveals a new study by the University of California San Diego’s Rady School of Management.
April 28, 2021
April 28, 2021 —
UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.
April 28, 2021
April 28, 2021 —
Computer scientists at the University of California San Diego received an Amazon Research Award to develop a voice assistant to better communicate with older adults. Their initial goal is to create a system capable of understanding and answering the medical questions of adults over age 65.
April 26, 2021
April 26, 2021 —
A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.